Zhejiang Conba Pharmaceutical Co., Ltd. logo

Zhejiang Conba Pharmaceutical Co., Ltd. (600572)

Market Open
10 Aug, 06:57
SSE SSE
¥
4. 34
0
0%
¥
11.37B Market Cap
- P/E Ratio
0.8% Div Yield
51.42M Volume
- Eps
¥ 4.34
Previous Close
Add Transaction
Day Range
4.31 4.4
Year Range
3.77 5.17
Want to track 600572 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600572 trading today higher at ¥4.34, an increase of 0% from yesterday's close, completing a monthly increase of 11.2821% or ¥0.44. Over the past 12 months, 600572 stock lost -2.4719%.
600572 pays dividends to its shareholders, with the most recent payment made on Jun 24, 2026. The next estimated payment will be in In 10 months on Jun 24, 2027 for a total of ¥0.15.
The last earnings report, released on May 09, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Zhejiang Conba Pharmaceutical Co., Ltd. has completed 5 stock splits, with the recent split occurring on Jun 15, 2016.
The company's stock is traded on one exchange.

600572 Chart

People also search for

SAIC Motor Corporation Limited
¥ 10.47
-0.0954%
Seres Group Co., Ltd.
¥ 55.54
-0.8745%
Great Wall Motor Co., Ltd.
¥ 15.68
-0.0637%
Fuyao Glass Industry Group Co., Ltd.
¥ 56.5
-0.159%
China Tourism Group Duty Free Corporation Limited
¥ 56.02
-0.3912%

Zhejiang Conba Pharmaceutical Co., Ltd. (600572) FAQ

What is the stock price today?

The current price is ¥4.34.

On which exchange is it traded?

Zhejiang Conba Pharmaceutical Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600572.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.8%.

What is its market cap?

As of today, the market cap is 11.37B.

Has Zhejiang Conba Pharmaceutical Co., Ltd. ever had a stock split?

Zhejiang Conba Pharmaceutical Co., Ltd. had 5 splits and the recent split was on Jun 15, 2016.

Zhejiang Conba Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Guoliang Luo CEO
SSE Exchange
CNE000001H86 ISIN
CN Country
8,411 Employees
24 Jun 2026 Last Dividend
15 Jun 2016 Last Split
12 Apr 2004 IPO Date

Overview

Zhejiang CONBA Pharmaceutical Co.,Ltd., originally known as Lanxi Yunshan Pharmaceutical Factory before its name change in October 1999, is a significant player in China's pharmaceutical industry. Founded in 1993 and headquartered in Hangzhou, China, CONBA is dedicated to the research and development, manufacture, and sales of a wide array of medicines and general health products. The company specializes in a range of pharmaceutical offerings, including Chinese herbal medicines, chemical pharmaceuticals, and biological products. It stands as a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd., underlining its strong position and heritage in the realm of traditional Chinese medicine alongside modern pharmaceutical practices.

Products and Services

Zhejiang CONBA Pharmaceutical Co.,Ltd. provides a plethora of products and services spanning across various types of pharmaceutical dosage forms and categories. Each category encapsulates the company's dedication to health and innovation:

  • Chinese herbal decoction pieces: These are traditional Chinese medicine products, carefully processed and prepared from raw herbal materials.
  • Chinese patent medicines: Ready-to-use medicinal products that are formulated from Chinese herbs, following traditional and modern practices to cater to various health conditions.
  • Chemical pharmaceutical products: This includes synthesized pharmaceuticals developed through rigorous research and development processes to address a wide range of ailments and health issues.
  • Chemical raw materials: CONBA supplies high-quality chemical raw materials that are essential for drug manufacture, underscoring the company’s involvement in various stages of the pharmaceutical production chain.
  • Medical devices: The company offers a range of medical devices for different therapeutic and diagnostic purposes, integrating modern technology into healthcare solutions.
  • Biological products: These include vaccines, blood products, and other biological materials used in prevention, treatment, and diagnosis of diseases.
  • Pharmaceutical dosage forms: CONBA's extensive repertoire includes various dosage forms such as:
    • Tablets, capsules, and pills for ease of oral administration.
    • Dripping pills and granules, providing alternatives in drug delivery and ensuring patient convenience.
    • Powders and injections for quick and effective treatment options.
    • Freeze-dried powder injections, which offer stability and longevity of pharmaceuticals.
    • Oral liquids and syrups for ease of use, especially in pediatric and geriatric medicine.
    • Nasal drops and ointments, catering to specific localized treatments.

Contact Information

Address: Binjiang Science and Technology Economic Park, Hangzhou, China, 310052
Phone: 86 571 8777 4710